Literature DB >> 309554

Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm.

J Zulman, R Jaffe, N Talal.   

Abstract

We studied the malignant lymphomas that developed in patients with Sjögren's syndrome and the antecedent benign salivary-gland lesions to determine their cellular characteristics. We used an immunoperoxidase technic that identified intracellular gamma, alpha and mu heavy chains and kappa and lambda light chains. In six of nine patients, the lymphomas were composed of cells containing intracytoplasmic immunoglobulin that was exclusively IgMK. The benign lymphoepithelial salivary-gland lesions preceding these malignant tumors consisted of approximately equal numbers of lymphoid cells containing either kappa or lambda light chains. Thus, in some patients with Sjögren's syndrome, there may be a progression in the lympho-proliferative lesions from a polyclonal infiltrate to a monoclonal neoplasm. Intracytoplasmic immunoglobulin identifies six of the nine cases as being B-cell in origin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 309554     DOI: 10.1056/NEJM197811302992204

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  36 in total

Review 1.  Therapy of Sjögren's syndrome.

Authors:  N M Moutsopoulos; H M Moutsopoulos
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Earring lesions of the parotid tail.

Authors:  Bronwyn E Hamilton; Karen L Salzman; Richard H Wiggins; H Ric Harnsberger
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

3.  Non-Hodgkin lymphomas of the thyroid. A clinico-pathological review of 29 cases applying the Lukes-Collins classification and an immunoperoxidase method.

Authors:  R Maurer; C R Taylor; R Terry; R J Lukes
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-08-23

4.  Hodgkin's disease occurring in primary Sjögren's syndrome.

Authors:  J M Martín-Santos; L Carretero; A Armentia; E Alonso; I Gil
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

5.  Evidence for oligoclonal B cell expansion in the peripheral blood of patients with rheumatoid arthritis.

Authors:  D A Fox; B R Smith
Journal:  Ann Rheum Dis       Date:  1986-12       Impact factor: 19.103

6.  Sjögren's and plasma cell variant Castleman disease: a case report.

Authors:  Yvonne A Dei-Adomakoh; Leslie Quarcoopome; Afua D Abrahams; Catherine I Segbefia; Dzifa I Dey
Journal:  Ghana Med J       Date:  2018-03

Review 7.  Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients.

Authors:  Michael Voulgarelis; Fotini N Skopouli
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 8.  Sjögren's syndrome--study of autoantigens and autoantibodies.

Authors:  John G Routsias; Athanasios G Tzioufas
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 9.  Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells.

Authors:  X Mariette
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

10.  Immunoglobulin-containing plasma cells in chronic parotitis and malignant lymphomas of the parotid gland. Comparing immunocytochemical observations of frequency and localization.

Authors:  C von Gumberz; G Seifert
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.